Abstract
Engineered iron oxide nanoparticles (IONP) offer the possibility of a wide range of medical uses, from clinical imaging to magnetically based hyperthermia for tumor treatment. These applications require their systemic administration in vivo. An important property of nanoparticles is their stability in biological media. For this purpose, a multicomponent nanoconstruct combining high colloidal stability and improved physical properties was synthesized and characterized. IONP were coated with an amphiphilic polymer (PMA), which confers colloidal stability, and were pegylated in order to obtain the nanoconstruct PEG-IONP-PMA. The aim of this study was to utilize cultured human endothelial cells (HUVEC) and murine macrophages, taken as model of cells exposed to NP after systemic administration, to assess the biocompatibility of PEG-IONP-PMA (23.1 ± 1.4 nm) or IONP-PMA (15.6 ± 3.4 nm). PEG-IONP-PMA, tested at different concentrations as high as 20 μg mL−1, exhibited no cytotoxicity or inflammatory responses. By contrast, IONP-PMA showed a concentration-dependent increase of cytotoxicity and of TNF-α production by macrophages and NO production by HUVECs. Cell uptake analysis suggested that after PEGylation, IONP were less internalized either by macrophages or by HUVEC. These results suggest that the choice of the polymer and the chemistry of surface functionalization are a crucial feature to confer to IONP biocompatibility.
Similar content being viewed by others
References
Abdelsaid MA, Pillai BA, Matragoon S, Prakash R, Al-Shabrawey M et al (2010) Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy. J Pharmacol Exp Ther 332(1):125–134
Afergan E, Ben David M, Epstein H, Koroukhov N, Gilhar D et al (2010) Liposomal simvastatin attenuates neointimal hyperplasia in rats. AAPS J 12(2):181–187
Anderson TJ (2003) Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev 8:71–86
Bana L, Minniti S, Salvati E, Sesana S, Zambelli V et al (2014) Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood–brain-barrier: implications for therapy of Alzheimer disease. Nanomedicine 10(7):1583–1590
Beauchamp MH, Sennlaub F, Speranza G, Gobeil F Jr, Checchin D et al (2004) Redoxdependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy. Free Radic Biol Med 37:1885–1894
Bulbarelli A, Lonati E, Brambilla A, Orlando A, Cazzaniga E et al (2012) Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation. Mol Cell Neurosci 49(4):415–422
Choi J, Zhang Q, Reipa V, Wang NS, Stratmeyer ME et al (2009) Comparison of cytotoxic and inflammatory responses of photoluminescent silicon nanoparticles with silicon micron-sized particles in RAW 264.7 macrophages. J Appl Toxicol 29(1):52–60
Choi YH, Jin GY, Li GZ, Yan GH (2011) Cornuside suppresses lipopolysaccharide-induced inflammatory mediators by inhibiting nuclear factor-kappa B activation in RAW 264.7 macrophages. Biol Pharm Bull 34(7):959–966
Cohen-Sela E, Dangoor D, Epstein H, Gati I, Danenberg HD et al (2006) Nanospheres of a bisphosphonate attenuate intimal hyperplasia. J Nanosci Nanotechnol 6(9–10):3226–3234
Colombo M, Mazzucchelli S, Montenegro JM, Galbiati E, Corsi F et al (2012a) Protein oriented ligation on nanoparticles exploiting O6-alkylguanine-DNA transferase (SNAP) genetically encoded fusion. Small 8(10):1492–1497
Colombo M, Sommaruga S, Mazzucchelli S, Polito L, Verderio P et al (2012b) Site-specific conjugation of scFv antibodies to nanoparticles by bioorthogonal strain-promoted alkyne-nitrone cycloaddition. Angew Chem Int Ed 51:496–499
Dan M, Bae Y, Pittman TA, Yokel RA (2015) Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models. Pharm Res 32(5):1615–1625
Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE (2008) Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5(4):487–495
Galley HF, Webster NR (2004) Physiology of the endothelium. Br J Anaesth 93:105–113
Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–4021
Hardman R (2006) A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Heath Perspect 114:165–172
Hevel JM, Marletta MA (1994) Nitric-oxide synthase assays. Methods Enzymol 233:250–258
Ito A, Shinkai M, Honda H, Kobayashi T (2005) Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 100(1):1–11
Jantzen F, Könemann S, Wolff B, Barth S, Staudt A et al (2007) Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells. J Physiol Pharmacol 58(3):503–514
Klostranec JM, Chan WCW (2006) Quantum dots in biological and biomedical research: recent progress and present challenges. Adv Mater 18:1953–1964
Kowluru RA, Odenbach S (2004) Effect of long-term administration of alphalipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 53:3233–3238
Kowluru RA, Kanwar M, Kennedy A (2007) Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp Diabetes Res 2007:21976
Lawrence T, Willoughby DA, Gilroy DW (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2(10):787–795
Li M, Kim HS, Tian L, Yu MK, Jon S et al (2012) Comparison of two ultrasmall superparamagnetic iron oxides on cyto-toxicity and MR imaging of tumors. Theranostics 2(1):76–85
Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Investig 117(5):1175–1183
Liong M, Shao H, Haun JB, Lee H, Weissleder R (2010) Carboxymethylated polyvinyl alcohol stabilizes doped ferrofluids for biological applications. Adv Mater 22:5168–5172
Lovren F, Pan Y, Shuklap P, Quan A, Teoh H et al (2009) Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. Am J Physiol Endocrinol Metab 296(6):E1440–E1449
Lucarelli M, Gatti AM, Savarino G, Quattroni P, Martinelli L et al (2004) Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. Eur Cytokine Netw 15:339–346
Mahmoudi M, Simchi A, Milani AS, Stroeve P (2009) Cell toxicity of superparamagnetic iron oxide nanoparticles. J Colloid Interface Sci 336(2):510–518
Mazzucchelli S, Colombo M, Verderio P, Rozek E, Andreata F et al (2013) Orientation-controlled conjugation of haloalkane dehalogenase fused homing peptides to multifunctional nanoparticles for the specific recognition of cancer cells. Angew Chem Int Ed Engl 52(11):3121–3125
Mitchell LA, Gao J, Vander Wal R, Gigliotti A et al (2007) Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol Sci 100:203–214
Nishikawa T, Iwakiri N, Kaneko Y, Taguchi A, Fukushima K et al (2009) Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae. Biomacromolecules 10:2074–2085
Orlando A, Re F, Sesana S, Rivolta I, Panariti A et al (2013) Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages. Int J Nanomed 8:1335–1347
Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87(1):315–424
Panariti A, Lettiero B, Alexandrescu R, Collini M, Sironi L et al (2013) Dynamic investigation of interaction of biocompatible iron oxide nanoparticles with epithelial cells for biomedical applications. J Biomed Nanotechnnol 9(9):1556–1569
Piazza M, Colombo M, Zanoni I, Granucci F, Tortora P et al (2011) Uniform LPS-loaded magnetic nanoparticles for the investigation of LPS/TLR4 signaling. Angew Chem Int 50:622–626
Romero-Calvo I, Ocón B, Martínez-Moya P, Suárez MD, Zarzuelo A et al (2010) Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 401(2):318–320
Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA et al (1994) Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 93:2236–2243
Sennlaub F, Courtois Y, Goureau O (2002) Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy. J Neurosci 22:3987–3993
Shevtsov MA, Nikolaev BP, Yakovleva LY, Marchenko YY, Dobrodumov AV et al (2014) Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors. Int J Nanomed 9:273–287
Simoni AR, Garcia MP, Azevedo RB, Chaves SB, Lacava ZG et al (2008) Evaluation of the binding properties of maghemite nanoparticle surface-coated with meso-2-3- dimercaptosuccinic acid to serum albumin. J Nanosci Nanotechnol 8(11):5813–5817
Soenen SJ, Rivera-Gil P, Montenegro JM, Parak WJ, De Smedt SC et al (2011) Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation. Nano Today 6:446–465
Ulivi V, Lenti M, Gentili C, Marcolongo G, Cancedda R et al (2011) Anti-inflammatory activity of monogalactosyldiacylglycerol in human articular cartilage in vitro: activation of an anti-inflammatory cyclooxygenase-2 (COX-2) pathway. Arthritis Res Ther 13(3):R92
Van Tiel ST, Wielopolski PA, Houston GC, Krestin GP, Bernsen MR (2010) Variations in labeling protocol influence incorporation, distribution and retention of iron oxide nanoparticles into human umbilical vein endothelial cells. Contrast Media Mol Imaging 5(5):247–257
Waldman WJ, Kristovich R, Knight DA, Dutta PK (2007) Inflammatory properties of iron-containing carbon nanoparticles. Chem Res Toxicol 20:1149–1154
Walkey CD, Olsen JB, Guo H, Emili A, Chan WC (2012) Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 134(4):2139–2147
Weksler B, Romero IA, Couraud PO (2013) The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 10(1):16
Wittenborn TR, Larsen EK, Nielsen T, Rydtoft LM, Hansen L et al (2014) Accumulation of nano-sized particles in a murine model of angiogenesis. Biochem Biophys Res Commun 443(2):470–476
Wu X, Tan Y, Mao H, Zhang M (2010) Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells. Int J Nanomed 9(5):385–399
Xiao N, Gu W, Wang H, Deng Y, Shi X et al (2014) T1-T2 dual-modal MRI of brain gliomas using PEGylated Gd-doped iron oxide nanoparticles. J Colloid Interface Sci 417:159–165
Zhu MT, Wang B, Wang Y, Yuan L, Wang HJ et al (2011) Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: risk factors for early atherosclerosis. Toxicol Lett 203(2):162–171
Acknowledgments
The authors report no conflict of interest. The authors are the sole responsible for the content and writing of the paper. This work was supported by grants from FAR 2010, FAR 2011, and “The MULAN Project” from Cariplo Foundation (Grant No. 2011-2096). We thank Pierre-Olivier Couraud for providing the hCMEC/D3 cells.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
11051_2015_3148_MOESM1_ESM.eps
Supplementary material 1 (EPS 6039 kb) HUVECs and macrophages RAW264.7 viability after PEG-IONP treatment. HUVECs (A) and macrophages RAW264.7 (B) were incubated with different concentrations (20/50/100 µg mL–1) of PEG-IONP for 1 and 24 h and the mitochondrial activity was determined by MTT assay. The results are reported as percentage respect to control (untreated cells). Data are means ± S.E. of three separate experiments performed in triplicate. The results were compared by Student’s t-test. **=p<0.01; cnt=untreated cells. See text for abbreviations
Rights and permissions
About this article
Cite this article
Orlando, A., Colombo, M., Prosperi, D. et al. Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages. J Nanopart Res 17, 351 (2015). https://doi.org/10.1007/s11051-015-3148-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-015-3148-5